These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25374634)

  • 21. New strategies for the treatment of breast cancer.
    Bentrem DJ; O'Regan RM; Jordan VC
    Breast Cancer; 2001; 8(4):265-74. PubMed ID: 11791116
    [No Abstract]   [Full Text] [Related]  

  • 22. A woman with breast cancer and severe impaired lactose tolerance: an intriguing therapeutic dilemma.
    Zagouri F; Dimitrakakis C; Dimopoulos MA; Tsigginou A; Antsaklis A; Papadimitriou CA
    Breast J; 2012; 18(6):628-9. PubMed ID: 23009609
    [No Abstract]   [Full Text] [Related]  

  • 23. Update: a 62-year-old woman with a new diagnosis of breast cancer.
    Farag N; Burns R; Come SE
    JAMA; 2008 Mar; 299(9):1055-6. PubMed ID: 18319415
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of combined noninvasive ductal and lobular carcinoma].
    Nagashima S; Sakurai K; Suzuki S; Hara Y; Waga E; Iizuka M; Fuchinoue T; Hirano T; Enomoto K; Tani M; Masuda S; Amano S; Koshinaga T
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2033-5. PubMed ID: 23267967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gallbladder metastases of breast cancer: from clinical-pathological patterns to diagnostic and therapeutic strategy.
    Di Vita M; Zanghì A; Lanzafame S; Cavallaro A; Piccolo G; Berretta M; Grosso G; Cappellani A
    Clin Ter; 2011; 162(5):451-6. PubMed ID: 22041804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of malignant pleural effusion].
    Kuzdzał J; Soja J; Szlubowski A; Zieliński M; Sładek K
    Pneumonol Alergol Pol; 2003; 71(3-4):186-91. PubMed ID: 14587426
    [No Abstract]   [Full Text] [Related]  

  • 27. Thymic malignancy in a breast cancer patient--is there an association with anti-estrogenic effects of tamoxifen?
    Oyan B; Aksoy S; Yavas O; Kars A; Turker A; Barista I
    Acta Oncol; 2004; 43(1):115-6. PubMed ID: 15068330
    [No Abstract]   [Full Text] [Related]  

  • 28. Lobular breast cancer metastasis to uterus during adjuvant tamoxifen treatment: A case report and review of the literature.
    Aytekin A; Bilgetekin I; Ciltas A; Ogut B; Coskun U; Benekli M
    J Cancer Res Ther; 2018; 14(5):1135-1137. PubMed ID: 30197363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring persistence to hormonal therapy in patients with breast cancer: accounting for temporary treatment discontinuation.
    Huiart L; Ferdynus C; Dell'Aniello S; Bakiri N; Giorgi R; Suissa S
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):882-9. PubMed ID: 24788986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer: Tamoxifen--when more might be better.
    Caldas C; Tannock IF
    Nat Rev Clin Oncol; 2013 Mar; 10(3):125-6. PubMed ID: 23380999
    [No Abstract]   [Full Text] [Related]  

  • 31. Tamoxifen therapy for patients with breast cancer.
    Huiart L; Ferdynus C; Giorgi R
    Lancet; 2013 Jun; 381(9883):2077. PubMed ID: 23769224
    [No Abstract]   [Full Text] [Related]  

  • 32. Extended adjuvant tamoxifen for breast cancer--a new era?
    Powles TJ
    Lancet; 2013 Mar; 381(9869):782-3. PubMed ID: 23219287
    [No Abstract]   [Full Text] [Related]  

  • 33. POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifen.
    Cohen AL; Factor RE; Mooney K; Salama ME; Wade M; Serpico V; Ostrander E; Nelson E; Porretta J; Matsen C; Bernard P; Boucher K; Neumayer L
    Breast; 2017 Feb; 31():219-223. PubMed ID: 27915204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The breast cancer prevention trial: should women at risk take tamoxifen?
    McKeon VA
    J Obstet Gynecol Neonatal Nurs; 1999; 28(6 Suppl 1):34-8. PubMed ID: 10608495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent versus sequential radiotherapy and tamoxifen in breast cancer - The CONSET trial is launched.
    Munshi A; Gupta D
    Acta Oncol; 2011 Jan; 50(1):154-5. PubMed ID: 20843175
    [No Abstract]   [Full Text] [Related]  

  • 37. New data refine role of adjuvant tamoxifen in early breast cancer.
    Am J Health Syst Pharm; 1996 Jan; 53(2):123-4. PubMed ID: 8653477
    [No Abstract]   [Full Text] [Related]  

  • 38. Stopping tamoxifen after 5 years of therapy for early breast cancer: does it alter quality of life?
    Hall PS; Walkington JP; Cameron DA
    Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):652. PubMed ID: 21703830
    [No Abstract]   [Full Text] [Related]  

  • 39. Thoracic manifestations of breast cancer and its therapy.
    Jung JI; Kim HH; Park SH; Song SW; Chung MH; Kim HS; Kim KJ; Ahn MI; Seo SB; Hahn ST
    Radiographics; 2004; 24(5):1269-85. PubMed ID: 15371608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant endocrine therapy for breast cancer: more questions than answers.
    Ellis MJ
    J Clin Oncol; 2005 Aug; 23(22):4842-4. PubMed ID: 15998901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.